Novavax (NVAX) Covid-19 Vaccine Induces Immune Response in First Human Study, Company Says - DJ

Go back to Novavax (NVAX) Covid-19 Vaccine Induces Immune Response in First Human Study, Company Says - DJ
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.22 +0.22 (2.44%)
Previous Close $9.00    52 Week High $9.23 
Open $9.15    52 Week Low $1.16 
Day High $9.36    P/E N/A 
Day Low $9.09    EPS $-0.30 
Volume 618,570